The study team applied a high-throughput single-cell contractility assay to primary human trabecular meshwork (TM) cells and tracked contractile behavior over time across controlled extracellular matrices and substrate stiffnesses. They reported that contractility emerged as a distribution of individual cellular states rather than a single averaged property. Some cells rapidly adopted strong contractile activity, while others remained weak or intermittently active. These differences persisted even within the same donor-derived cultures.
ECM composition produced reproducible, distinct contractile programs. Collagen IV biased the population toward a rapid convergence on a highly contractile state. Collagen I led to a slower transition that nevertheless moved cells toward elevated contractility. Fibronectin preserved a heterogeneous population with persistently low contractility. The authors noted that these programs were context-dependent: the same cell could occupy different contractile states when the extracellular protein milieu changed. Substrate stiffness further conditioned these responses. As stiffness increased, the range of DEX-responsive behavior narrowed and, on pathologically stiff substrates, the dexamethasone-associated prolongation of activity was absent. The data therefore indicate that both ECM biochemical composition and mechanical stiffness are necessary determinants of TM single-cell mechanics.
Investigators probed intracellular modulation using pharmacologic perturbations and related the outcomes to the extracellular context. Treatment with dexamethasone (DEX) did not produce a uniform rise in contractility across the TM cell population. Instead, the cohort showed selective prolongation of contractile activity in the subset of cells that were already mechanically active, effectively sustaining high-contractility states in that subpopulation. This selective effect implies that glucocorticoid responsiveness is gated by pre-existing cellular state and by the extracellular mechanical environment.
By contrast, ROCK inhibition produced a different pattern. The study team observed that ROCK inhibitors overrode basal and DEX-induced programs, driving the entire heterogeneous population into a uniformly low-contractility state. In other words, ROCK pathway suppression collapsed the distribution of contractile states rather than shifting only a subset. Together these findings indicate that intracellular pathways can either reinforce heterogeneity (as with DEX) or suppress it (as with ROCK inhibition), and that extracellular stiffness modulates the magnitude and presence of those effects.
The authors also compared intracellular protein abundance against measured mechanical behavior at single-cell resolution. Data indicated weak pooled associations between protein levels and contractile metrics. Rather than showing consistent molecular–mechanical coupling across donors, the pooled weak associations reflected divergent, donor-specific relationships. In plain terms: a marker that associated with contractility in one donor did not reliably predict contractility in another. The study team therefore concluded that static molecular marker abundance, measured at the protein level, poorly predicts functional single-cell mechanical state.
This work leaves several concrete experimental questions open. The manuscript did not report mechanistic details explaining the donor-specific coupling between protein abundance and contractility, and it did not establish causal molecular drivers that consistently map to functional states across donors. The authors did not report in vitro-to-in vivo validation linking identified single-cell contractile states to outflow resistance or intraocular pressure changes in human tissue. Those gaps define next steps: identify causal molecular regulators that reproducibly determine single-cell mechanical states, and determine how in vitro ECM compositions and stiffnesses correspond to TM microenvironments in health and glaucoma.
Limitations documented by the authors include the weak pooled correlations between molecular markers and mechanics and the observed donor-specific variability; the study therefore cautions against inferring TM cell mechanical identity solely from static protein abundance or from population-averaged mechanical measures. The findings establish single-cell contractile state as a distinct functional axis of TM identity and frame specific unanswered questions for follow-up experiments: what establishes donor-specific molecular–mechanical coupling, and how do these single-cell programs relate to physiological outflow resistance in vivo?